B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CDC37

MOLECULAR TARGET

cell division cycle 37, HSP90 cochaperone

UniProt: Q16543NCBI Gene: 111402 compounds

CDC37 (cell division cycle 37, HSP90 cochaperone) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CDC37

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1celastrol1.102
219-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]0.691

About CDC37 as a Drug Target

CDC37 (cell division cycle 37, HSP90 cochaperone) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented CDC37 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CDC37 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.